Travelers Today By Althea Serad
Superbugs 10 Million 2050 - Drug resistant superbugs or infections could reportedly kill an extra 10 million people a year. Unless drastic measures are taken and the global spread is not cut short, the superbugs 10 million 2050 phenomenon could cost up to $100 trillion in economic losses by 2050, according to a British government-commissioned report.
The superbugs are currently mixed up in 700,000 deaths each year, compared with 130,000 for measles, 1.4 million for diarrheal disease and 8.2 million for cancer, the report on the superbugs 10 million 2050 occurrence.
According to the review, the trend is reportedly growing.
"The importance of effective antimicrobial drugs cannot be overplayed," the review also said.
The analysis on the superbugs 10 million 2050 happening was presented by Former Goldman Sachs chief economist Jim O'Neill, who also presented that total cost of economic loss if such a thing would happen could reach up to $100tn (£63tn).
O'Neill was appointed by U.K.Prime Minister David Cameron in July to head the review on antimicrobial resistance, according to the BBC.
"This is a significant global problem, perhaps on the same dimension as climate change," said O'Neill of the superbugs 10 million 2050 phenomenon. "Trying to solve it is a bit like climate change. The cost of stopping the problem is significantly lower than the cost of not stopping the problem."
Maggie Fox NBC News
Sep. 16, 2013 at 1:03 PM ET
More than two million people are infected by drug-resistant germs each year, and 23,000 die of their infections, federal health officials reported Monday. The biggest killer by far is C. difficile, the Centers for Disease Control and Prevention reports in its first big overview of a growing problem.
Doctors have been warning of the problem for decades, yet up to half the prescriptions written for antibiotics are unnecessary, the CDC report says. And all these unneeded antibiotics are making the superbug problem worse.
But there is some good news - CDC experts say better care has cut the number of a frightening infection called methicillin-resistant Staphylococcus aureus (MRSA). There were more than 30,000 fewer MRSA in 2011 compared to 2005, they reported separately in the Journal of the American Medical Association.